Gamida Cell Ltd, an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that company management will present its corporate highlights at the following upcoming virtual investor conferences:
Evercore ISI 4th Annual HealthCONx Conference, November 30, 2021 with a presentation at 1:25 p.m. ET.
Piper Sandler 33rd Annual Virtual Healthcare Conference, December 2, 2021. Company pre-recorded fireside chat will become available to registered conference attendees on Monday, November 22, 2021 at 10:00 a.m. ET.
JMP Securities Hematology and Oncology Summit, December 6, 2021 with a fireside chat at 10:00 a.m. ET.
Upcoming Catalysts NiCord (omidubicel) Hematologic Malignancies - Phase 3 Phase 3 data to be presented at ASH December 13, 2021. BLA filing due 1H 2022.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.